Ambrus, J.L. , Ambrus, C.M., Sokal, J.E., Markus, G., Back, N., Stutzman, L., Razis, D., Ross, C.A., Smith, B.H., Rekate, A.C., Collins, G.L., Kline, D.L., AND Fishman, J.B.: Clinical pharmacology of various types of fibrinolytic enzyme preparations. Am. J. Cardiol.6: 462, 1960.
2.
Cliffton, E.E. : Use of plasmin in treatment of intravascular thrombosis. J. Am. Geriatrics Soc., 6: 118, 1958.
3.
Back, N., Ambrus, J.L., Simpson, C.L., AND Shulman, S.: Study on effect of streptokinase-activated plasmin (fibrinolysin) on clots in various stages of organization. J. Clin. Invest., 37: 864, 1958.
4.
Wessler, S.: Studies in intravascular coagulation. III. pathogenesis of serum induced venous thrombus. J. Clin. Invest., 34: 647, 1955.
5.
Boyles, P.W. , Meyer, W.H., Graff, J., Ashley, C.C., AND Ripic, R.G.: Comparative effectiveness of intravenous and intra-arterial fibrinolysin therapy. Am. J. Cardiol., 6: 439, 1960.
6.
Nydick, I., Ruegsegger, P., Bouvier, C., Hutter, R.V., Abarquez, R., Cliffton, E.E., AND Ladue, J.S.: Salvage of heart muscle by fibrinolytic therapy after experimental coronary occlusion. Am. Heart J., 61: 93, 1961.
7.
Sussman, B.J. , AND Fitch, T.S.P.: Thrombolysis with fibrinolysin in cerebral arterial occlusion. Angiology, 12: 169, 1961.
8.
Areng, C.D.: Quoted from Med. Trib., p. 13, April 16, 1962.
